Eleonora Olivetta Selected Research

nef Gene Products (nef Gene Product)

1/2014	HIV-1 Nef impairs key functional activities in human macrophages through CD36 downregulation.
4/2009	HIV-1 Nef induces p47(phox) phosphorylation leading to a rapid superoxide anion release from the U937 human monoblastic cell line.
9/2005	HIV-1 Nef regulates the release of superoxide anions from human macrophages.
12/2000	T-tropic human immunodeficiency virus (HIV) type 1 Nef protein enters human monocyte-macrophages and induces resistance to HIV replication: a possible mechanism of HIV T-tropic emergence in AIDS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleonora Olivetta Research Topics

Disease

7	Neoplasms (Cancer) 05/2021 - 04/2015
5	Infections 01/2020 - 09/2002
5	Acquired Immunodeficiency Syndrome (AIDS) 11/2018 - 12/2000
2	COVID-19 01/2022 - 09/2021
1	Hepatitis B 11/2018
1	Virus Diseases (Viral Diseases) 11/2018
1	Opportunistic Infections (Opportunistic Infection) 01/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2002
4	nef Gene Products (nef Gene Product)IBA 01/2014 - 12/2000
3	AntigensIBA 01/2019 - 01/2017
2	Immunoglobulin A (IgA)IBA 01/2022 - 09/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 09/2021
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2018
2	VaccinesIBA 11/2018 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 01/2017
1	Peptides (Polypeptides)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2018
1	AutoantigensIBA 01/2018
1	plerixafor FDA Link 04/2015
1	MicroRNAs (MicroRNA)IBA 04/2015
1	Superoxides (Superoxide)IBA 09/2005
1	AnionsIBA 09/2005
1	vesicular stomatitis virus G proteinIBA 11/2003

Therapy/Procedure

2	Therapeutics 05/2021 - 01/2020
1	Immunotherapy 01/2018
1	Intramuscular Injections 01/2018